Distributor inventory | Tablet
Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg (per tablet)
Treatment of hypertension (high blood pressure), especially when single-agent therapy is not adequate; helps reduce risk of cardiovascular complications associated with uncontrolled BP.
Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking AT1 receptors, lowering blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases salt and water excretion via the kidneys, reducing blood volume and BP. Together they provide additive BP lowering.
Oral tablet: take as prescribed, usually once daily at the same time each day, with or without food. Swallow whole with water. Do not stop abruptly without medical advice; monitor BP regularly.
Common side effects of TELZEAL-H TAB may include:
Not recommended in pregnancy (may harm fetus); use caution in breastfeeding. Risk of low BP especially with dehydration/diuretics; maintain adequate fluids. Monitor kidney function and electrolytes (potassium, sodium) periodically; caution in kidney impairment, liver disease, diabetes, gout, and history of angioedema. May increase uric acid and blood sugar. Avoid potassium supplements/salt substitutes unless advised. Photosensitivity can occur with hydrochlorothiazide.
